Mergers & Acquisitions Mergers & Acquisitions

Comment: Pharmacy benefit managers’ contracting practices criticized in submissions to US FTC

By Max Fillion and Khushita Vasant
  • 11 Oct 2021 18:45
  • 11 Oct 2021 20:01
Pharmacy benefit managers’ contracting practices were attacked as anticompetitive in submissions by pharmacist industry groups to the US Federal Trade Commission as part of the agency’s inquiry into unfair contract terms.
PBMs have received increasing scrutiny in recent years as lawmakers and regulators contemplate reforms aimed at boosting competition in

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US

Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News